Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zellkulturlabor für Klinische Prüfung was a specialized German contract research organization (CRO) focused on cell culture services and clinical trial support. Based in Munich, the company provided expertise in mycoplasma detection, cytotoxicity testing, and the preparation of cell-based materials for clinical phases I through IV. It was closely associated with the Institut für angewandte Zellkultur (IAZ) and served the pharmaceutical and biotech industries in validating cell-derived products. Their services were critical for ensuring compliance with regulatory standards for cell-based therapeutics and vaccines. The laboratory was particularly known for its work in standardized cell cultivation and safety testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zellkulturlabor für Klinische Prüfung.